Alx Oncology Stock Forward View
| ALXO Stock | USD 1.57 0.20 14.60% |
Alx Stock outlook is based on your current time horizon.
As of today, The value of RSI of Alx Oncology's share price is at 54. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Alx Oncology, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
Using Alx Oncology hype-based prediction, you can estimate the value of Alx Oncology Holdings from the perspective of Alx Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Alx Oncology Holdings on the next trading day is expected to be 1.55 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 5.11. Alx Oncology after-hype prediction price | USD 1.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Alx Oncology to cross-verify your projections. Alx Oncology Additional Predictive Modules
Most predictive techniques to examine Alx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alx using various technical indicators. When you analyze Alx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Alx Oncology Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of Alx Oncology Holdings on the next trading day is expected to be 1.55 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 5.11.Please note that although there have been many attempts to predict Alx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Alx Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Alx Oncology Stock Forecast Pattern
| Backtest Alx Oncology | Alx Oncology Price Prediction | Buy or Sell Advice |
Alx Oncology Forecasted Value
In the context of forecasting Alx Oncology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Alx Oncology's downside and upside margins for the forecasting period are 0.02 and 8.44, respectively. We have considered Alx Oncology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Alx Oncology stock data series using in forecasting. Note that when a statistical model is used to represent Alx Oncology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.5739 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0837 |
| MAPE | Mean absolute percentage error | 0.0623 |
| SAE | Sum of the absolute errors | 5.1061 |
Predictive Modules for Alx Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alx Oncology Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alx Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alx Oncology After-Hype Price Density Analysis
As far as predicting the price of Alx Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alx Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alx Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Alx Oncology Estimiated After-Hype Price Volatility
In the context of predicting Alx Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alx Oncology's historical news coverage. Alx Oncology's after-hype downside and upside margins for the prediction period are 0.08 and 8.45, respectively. We have considered Alx Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Alx Oncology is extremely dangerous at this time. Analysis and calculation of next after-hype price of Alx Oncology Holdings is based on 3 months time horizon.
Alx Oncology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Alx Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alx Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alx Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 6.88 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.57 | 1.57 | 0.00 |
|
Alx Oncology Hype Timeline
Alx Oncology Holdings is presently traded for 1.57. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Alx is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.26%. %. The volatility of related hype on Alx Oncology is about 0.0%, with the expected price after the next announcement by competition of 1.57. About 66.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. Alx Oncology Holdings recorded a loss per share of 2.01. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Alx Oncology to cross-verify your projections.Alx Oncology Related Hype Analysis
Having access to credible news sources related to Alx Oncology's direct competition is more important than ever and may enhance your ability to predict Alx Oncology's future price movements. Getting to know how Alx Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alx Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DTIL | Precision BioSciences | 0.00 | 0 per month | 0.00 | (0.28) | 4.71 | (8.82) | 15.28 | |
| RPTX | Repare Therapeutics | 0.00 | 0 per month | 1.14 | 0.13 | 3.74 | (2.81) | 35.71 | |
| GUTS | Fractyl Health Common | 0.00 | 0 per month | 3.68 | 0.14 | 11.89 | (5.49) | 31.63 | |
| ATYR | aTyr Pharma | 0.00 | 0 per month | 3.67 | 0.01 | 7.79 | (6.10) | 22.83 | |
| ARTV | Artiva Biotherapeutics Common | 0.00 | 0 per month | 7.65 | 0.04 | 8.00 | (11.11) | 118.69 | |
| ADVM | Adverum Biotechnologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BMEA | Biomea Fusion | 0.00 | 0 per month | 0.00 | (0.03) | 9.38 | (8.33) | 28.51 | |
| MGX | Metagenomi Common Stock | 0.00 | 0 per month | 0.00 | (0.18) | 6.02 | (6.21) | 18.63 | |
| IMUX | Immunic | 0.00 | 0 per month | 0.00 | (0.08) | 9.43 | (6.58) | 21.44 | |
| STRO | Sutro Biopharma | 0.00 | 0 per month | 5.38 | 0.11 | 11.76 | (7.78) | 27.28 |
Other Forecasting Options for Alx Oncology
For every potential investor in Alx, whether a beginner or expert, Alx Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Alx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Alx. Basic forecasting techniques help filter out the noise by identifying Alx Oncology's price trends.Alx Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alx Oncology stock to make a market-neutral strategy. Peer analysis of Alx Oncology could also be used in its relative valuation, which is a method of valuing Alx Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Alx Oncology Market Strength Events
Market strength indicators help investors to evaluate how Alx Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alx Oncology shares will generate the highest return on investment. By undertsting and applying Alx Oncology stock market strength indicators, traders can identify Alx Oncology Holdings entry and exit signals to maximize returns.
Alx Oncology Risk Indicators
The analysis of Alx Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alx Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.63 | |||
| Semi Deviation | 6.09 | |||
| Standard Deviation | 6.88 | |||
| Variance | 47.4 | |||
| Downside Variance | 39.9 | |||
| Semi Variance | 37.05 | |||
| Expected Short fall | (6.18) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Alx Oncology
The number of cover stories for Alx Oncology depends on current market conditions and Alx Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alx Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alx Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Alx Oncology Short Properties
Alx Oncology's future price predictability will typically decrease when Alx Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alx Oncology Holdings often depends not only on the future outlook of the potential Alx Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alx Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.2 M | |
| Cash And Short Term Investments | 127.8 M |
Check out Historical Fundamental Analysis of Alx Oncology to cross-verify your projections. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Stock sector continue expanding? Could Alx diversify its offerings? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alx Oncology data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Alx Oncology's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alx Oncology represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Alx Oncology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.